Literature DB >> 3386817

Practical application of a low-protein diet for Parkinson's disease.

D Riley1, A E Lang.   

Abstract

Thirty-eight patients with Parkinson's disease were treated with a protein-restricted diet in addition to their usual drug regime. Patients who had failed to obtain a significant response to levodopa previously did not benefit. Sixty percent of those with fluctuations in response to levodopa improved, primarily obtaining an increase in the ratio of "on" to "off" hours. Benefit was always noted within a week of diet initiation. The diet was well tolerated with a low incidence of side effects, which could usually be reversed by a reduction in levodopa dosage. A low-protein diet is a simple adjunct to levodopa therapy that can be readily instituted on an outpatient basis. It may improve even those patients with fluctuations who have failed to obtain optimal benefit from all forms of manipulation of the dosage schedule of levodopa or the addition of newer ancillary medications.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3386817     DOI: 10.1212/wnl.38.7.1026

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Parkinson's Disease: Motor Fluctuations.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

Review 2.  The on-off phenomenon.

Authors:  A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 3.  New directions in the drug treatment of Parkinson's disease.

Authors:  J L Montastruc; O Rascol; J M Senard
Journal:  Drugs Aging       Date:  1996-09       Impact factor: 3.923

4.  Influence of fluctuations of plasma large neutral amino acids with normal diets on the clinical response to levodopa.

Authors:  J G Nutt; W R Woodward; J H Carter; T L Trotman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

5.  Parkinson's disease and motor fluctuations.

Authors:  Vanessa K Hinson
Journal:  Curr Treat Options Neurol       Date:  2010-05       Impact factor: 3.598

6.  The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.

Authors:  H Lennernäs; D Nilsson; S M Aquilonius; O Ahrenstedt; L Knutson; L K Paalzow
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

Review 7.  Pharmacokinetic optimisation in the treatment of Parkinson's disease.

Authors:  M Contin; R Riva; F Albani; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

Review 8.  Gastrointestinal dysfunction in the synucleinopathies.

Authors:  Kathryn A Chung; Ronald F Pfeiffer
Journal:  Clin Auton Res       Date:  2020-11-27       Impact factor: 4.435

9.  Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial.

Authors:  Abby Willcox; Lucy Culliford; Lucy Ellis; Chris A Rogers; Angela Cree; Usha Chakravarthy; Sarah Ennis; Francine Behar-Cohen; Barnaby C Reeves; Sobha Sivaprasad; Andrew Lotery
Journal:  Eye (Lond)       Date:  2018-09-07       Impact factor: 3.775

10.  Diet with LPP for renal patients increases daily energy expenditure and improves motor function in parkinsonian patients with motor fluctuations.

Authors:  Michela Barichella; Chiara Savardi; Andrea Mauri; Agnieszka Marczewska; Antonella Vairo; Cinzia Baldo; Arianna Massarotto; Sara Elisabetta Cordara; Gianni Pezzoli
Journal:  Nutr Neurosci       Date:  2007 Jun-Aug       Impact factor: 4.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.